Advertisements



FDA Approves Nonopioid Treatment for Opioid Withdrawal Symptoms

The U.S. Food and Drug Administration has approved the first nonopioid treatment to help adults manage opioid withdrawal symptoms as the agency looks to continue to encourage the development of therapies to help patients suffering from addiction......»»

Category: smallbizSource: wsjMay 16th, 2018

The Wall Street Journal: Senate approves bipartisan bill to fight opioid epidemic

The Senate on Monday passed sweeping, bipartisan legislation aimed at combating the opioid epidemic through new research, treatment and help for families affected by addiction......»»

Category: topSource: marketwatchSep 17th, 2018

FDA approves Teva "s Cassipa for maintenance treatment of opioid dependence

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 7th, 2018

Incarcerated opioid addicts often have to tough out withdrawal. Some jails say they have a better way.

Symptoms from heroin, fentanyl and prescription-painkiller withdrawal can include severe diarrhea and vomiting and ultimately kil.....»»

Category: topSource: usatodayMay 23rd, 2018

The first drug for opioid withdrawal has gotten the green light — and it targets risky symptoms that others ignore

Darren Staples / Reuters More than 63,000 Americans died of opioid drug overdoses last year, more than the number killed in car crashes. On Wednesday, the FDA approved the first drug designed to treat th.....»»

Category: topSource: businessinsiderMay 17th, 2018

Grant awarded to expand opioid treatment to Medicaid population

A three-year federal grant will allow three area health providers to expand access to medication-assisted treatment to Medicaid recipients with opioid addiction. The $1.5 million grant from the Substance Abuse and Mental Health Services Administration.....»»

Category: topSource: bizjournals8 hr. 15 min. ago

Akorn"s stock soars after FDA approves ANDA for hypotrichosis of eyelashes treatment

Shares of Akorn Inc. ran up 13% in premarket trade Wednesday, putting them on track for a seventh-straight gain, after the .....»»

Category: topSource: marketwatchOct 10th, 2018

FDA approves Akcea, Ionis treatment Tegsedi

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallOct 5th, 2018

Local opioid treatment centers acquired by New Jersey company

An opioid addiction treatment group has acquired two practices in the Dayton region......»»

Category: topSource: bizjournalsOct 5th, 2018

FDA Approves Paratek"s Bacterial Pneumonia, Skin Infection Treatment

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) shares reacted positively following the announcement of a Food and Drug Administration's approved treatment. read more.....»»

Category: blogSource: benzingaOct 3rd, 2018

VistaGen shares surge 13% after FDA grants fast track status to non-opioid pain treatment

VistaGen Therapeutics Inc.'s stock surged 13% in premarket trade Wednesday, after the company said it h.....»»

Category: topSource: marketwatchOct 3rd, 2018

VistaGen wins FDA fast track designation for non-opioid pain treatment

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»

Category: topSource: marketwatchOct 3rd, 2018

Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags

Migraine sufferers often have many days of debilitating head pain a month. These drugs could cut down or even eliminate those symptoms, but they come with a large price tag......»»

Category: topSource: marketwatchSep 27th, 2018

Acorda shares slide 19% premarket after FDA delays review of Parkinson"s treatment

Shares of Acorda Therapeutics Inc. slid 19% Thursday, after the company said the U.S. Food and Drugs Administration has extended the review period for a treatment for symptoms of Parkinso.....»»

Category: topSource: marketwatchSep 13th, 2018

Purdue Pharma is offering free opioid treatment in legal talks

The company that created OxyContin is offering free doses of an opioid-abuse treatment as part of its offer to resolve more than 1,000 lawsuits accusing the drugmaker of helping fuel the opioid crisis, according to people familiar with the negotiations......»»

Category: topSource: moneycentralSep 11th, 2018

"High-need" Genesee County funded for addictions services

With a recognition of high need for opioid treatment programs, Genesee County will receive funding to expand addiction services. The Genesee Council on Alcoholism and Substance Abuse Inc. will receive $650,000 in federal funding through the Opioid St.....»»

Category: topSource: bizjournalsSep 8th, 2018

OxyContin Billionaire Granted Patent for Opioid Addiction Treatment

Richard Sackler was given a patent for a novel form of buprenorphine, a mild opiate that controls drug cravings. Purdue Pharma has long been criticized for aggressively marketin.....»»

Category: europeSource: fortuneSep 7th, 2018

OxyContin billionaire granted patent for addiction treatment

A billionaire pharmaceuticals executive who has been blamed for spurring the US opioid crisis stands to profit from the epidemic after he patented a new treatment for drug addicts......»»

Category: topSource: moneycentralSep 7th, 2018

OxyContin billionaire granted patent for addiction treatment

A billionaire pharmaceuticals executive who has been blamed for spurring the US opioid crisis stands to profit from the epidemic after he patented a new treatment for drug addicts......»»

Category: topSource: moneycentralSep 7th, 2018

A member of the rich family behind OxyContin was granted a patent for addiction treatment

AP Photo/Toby Talbot, File Dr. Richard Sackler, a member of the family that owns Purdue Pharma, was one of the six inventors awarded a patent for a treatment for opioid-use disorder. Critics told the Financial Times th.....»»

Category: topSource: businessinsiderSep 7th, 2018

The FDA Approves Merck"s Anti-HIV-1 Drugs

Merck's products represent a treatment option for chronically infected adult patients in the USRelated Stocks: MRK,.....»»

Category: smallbizSource: nytAug 31st, 2018